- Home
- SILO vs DSS Comparison
SILO vs DSS Comparison
Compare SILO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- DSS
- Stock Information
- Founded
- SILO 2010
- DSS 1984
- Country
- SILO United States
- DSS United States
- Employees
- SILO N/A
- DSS N/A
- Industry
- SILO Apparel
- DSS Containers/Packaging
- Sector
- SILO Consumer Discretionary
- DSS Consumer Discretionary
- Exchange
- SILO Nasdaq
- DSS Nasdaq
- Market Cap
- SILO 8.8M
- DSS 7.3M
- IPO Year
- SILO N/A
- DSS N/A
- Fundamental
- Price
- SILO $1.35
- DSS $0.94
- Analyst Decision
- SILO
- DSS
- Analyst Count
- SILO 0
- DSS 0
- Target Price
- SILO N/A
- DSS N/A
- AVG Volume (30 Days)
- SILO 228.4K
- DSS 17.2K
- Earning Date
- SILO 03-04-2025
- DSS 03-26-2025
- Dividend Yield
- SILO N/A
- DSS N/A
- EPS Growth
- SILO N/A
- DSS N/A
- EPS
- SILO N/A
- DSS N/A
- Revenue
- SILO $72,102.00
- DSS $25,019,000.00
- Revenue This Year
- SILO $1.86
- DSS N/A
- Revenue Next Year
- SILO N/A
- DSS N/A
- P/E Ratio
- SILO N/A
- DSS N/A
- Revenue Growth
- SILO N/A
- DSS N/A
- 52 Week Low
- SILO $0.77
- DSS $0.77
- 52 Week High
- SILO $4.50
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- SILO 40.14
- DSS 55.12
- Support Level
- SILO $1.39
- DSS $0.90
- Resistance Level
- SILO $1.52
- DSS $0.96
- Average True Range (ATR)
- SILO 0.14
- DSS 0.06
- MACD
- SILO -0.05
- DSS 0.01
- Stochastic Oscillator
- SILO 0.97
- DSS 76.96
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.